We only have this paper's title and publication details.
Read it at the sourceObservational analysis reveals decreased immune checkpoint inhibitors and increased CD3zeta in glioblastoma patients, suggesting potential therapeutic implications.
No takes yet. Share an insight, caveat, or question.
Levite et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: